Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: Results from the Study of Optimal Treatment in Hypertensive Patients with Anti-AT 1-Receptor Autoantibodies trial

Journal of the American Society of Hypertension

Volumn 8, Issue 1, 2014, Pages 21-27

  Sun, Yanxiang ^a,b   Liao, Yuhua ^a   Yuan, Yong ^b   Feng, Li ^b   Ma, Shihui ^b   Wei, Feng ^a   Wang, Min ^a   Zhu, Feng ^a  

^a Union Hospital   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

angiotensin receptor blockers; autoantibodies; Hypertension; polymorphism

Indexed keywords

AGTR1 PROTEIN, HUMAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AUTOANTIBODY; BENZIMIDAZOLE DERIVATIVE; CANDESARTAN; TETRAZOLE DERIVATIVE;

ANGIOTENSIN-RECEPTOR BLOCKERS; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; IMMUNOLOGY; MALE; MIDDLE AGED; POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ANGIOTENSIN-RECEPTOR BLOCKERS; AUTOANTIBODIES; HYPERTENSION; POLYMORPHISM;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AUTOANTIBODIES; BENZIMIDAZOLES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES;

EID: 84895073977     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2013.08.002     Document Type: Article

References (31)

1. D. Dzielak The immune system and hypertension Hypertension 19 suppl I 1992 I36 I44
2. M.L. Fu Do immune system changes have a role in hypertension? J Hypertens 13 1995 1259 1265
3. M.L. Fu, H. Herlitz, W. Schulze, G. Wallukat, P. Micke, and P. Eftekhari et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension J Hypertens 18 2000 945 953
4. G. Wallukat, V. Homuth, T. Fischer, C. Lindschau, B. Horstkamp, and A. Jüpner et al. Patients with preeclampsia develop agonistic autoantibodes against the angiotensin AT1 receptor J Clin Invest 103 1999 945 952
5. R. Dechend, V. Homuth, G. Wallukat, J. Kreuzer, J.K. Park, and J. Theuer et al. AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor Circulation 101 2000 2382 2393
6. T.M. Thway, S.G. Shlykov, M.C. Day, B.M. Sanborn, L.C. Gilstrap III, and Y. Xia et al. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation Circulation 110 2004 1612 1619
7. R. Dechend, V. Homuth, G. Wallukat, D.N. Müller, M. Krause, and J. Dudenhausen et al. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia J Soc Gynecol Investig 13 2006 79 86
8. F. Wei, X.J. Jia, S.Q. Yu, Y. Gu, L. Wang, and X.M. Guo et al. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies Heart 97 2011 479 484
9. S.T. Turner, G.L. Schwartz, A.B. Chapman, W.D. Hall, and E. Boerwinkle Antihypertensive pharmacogenetics: getting the right drug into the right patient J Hypertens 19 2001 1 11
10. U. Liljedahl, J. Karlsson, H. Melhus, L. Kurland, M. Lindersson, and T. Kahan et al. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response Pharmacogenetics 13 2003 7 17
11. L. Kurland, H. Melhus, J. Karlsson, T. Kahan, K. Malmqvist, and K.P. Ohman et al. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type I antagonist treatment in hypertensive patients J Hypertens 19 2001 1783 1787
12. L. Frazier, S.T. Turner, G.L. Schwartz, A.B. Chapman, and E. Boerwinkle Multilocus effects of the renin-angiotensin -aldosterone system genes on blood pressure response to a thiazide diuretic Pharmacogenomics J 4 2004 17 23
13. J.A. Miller, K. Thai, and J.W. Scholey Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II Kidney Int 56 1999 2173 2180
14. X.W. Su, L. Lee, X.H. Li, J. Lv, Y.H. Hu, and S.Y. Zhan et al. Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor Circulation 115 2007 725 732
15. M. Vincent, N. Samani, D. Gauguier, J. Thompson, G. Lathrop, and J. Sassard A pharmacogenetic approach to blood pressure in Lyon hypertensive rats J Clin Invest 100 1997 2000 2006
16. D.K. Arnett, S.A. Claas, and S.P. Glasser Pharmacogenetics of antihypertensive treatment Vascul Pharmacol 44 2006 107 118
17. Y.H. Liao, Y.M. Wei, M. Wang, Z.H. Wang, H.T. Yuan, and L.X. Cheng Autoantibodies against AT1-receptor and alpha1- adrenergic receptor in patients with hypertension Hypertens Res 25 2002 641 646
18. A. Bonnardeaux, E. Davies, X. Jeunemaitre, I. Fery, A. Charru, and E. Clauser et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension Hypertension 24 1994 63 69
19. W.Y. Wang, R.Y. Zee, and B.J. Morris Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension Clin Genet 51 1997 31 34
20. S.Y. Su, J.H. Chena, J.G. Zhao, J.F. Huang, X.L. Wang, and R.S. Chen et al. Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis study Pharmacogenetics 14 2004 673 681
21. X. Zhang, J. Erdmann, V. Regitz-Zagrosek, S. KuÈrzinger, H.W. Hensec, and H. Schunkerta Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene J Hypertens 18 2000 267 272
22. Y.Y. Shi, and L. He SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphic loci Cell Res 15 2005 97 98
23. Y.X. Sun, H.Y. Zhang, Y.M. Wei, F. Zhu, M. Wang, and Y.H. Liao The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension Chin Med J (Engl) 121 2008 43 48
24. X.L. Yang, V. Wang, H.L. Chang, S.L. Zhang, L.H. Yang, and X.L. Wang et al. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation J Hypertens 26 2008 1629 1635
25. C.C. Zhou, Y.J. Zhang, R.A. Irani, H. Zhang, T.J. Mi, and E.J. Popek et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice Nat Med 8 2008 855 862
26. A.H. Siddiqui, R.A. Irani, S.C. Blackwell, S.M. Ramin, R.E. Kelllems, and Y. Xia Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia-correlation with disease severity Hypertension 55 2010 386 393
27. K. Kainulainen, M. Perola, J. Terwilliger, J. Kaprio, M. Koskenvuo, and A.C. Syvanen et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension Hypertension 33 1999 844 849
28. C.T. Tsai, D. Fallin, F.T. Chiang, J.J. Hwang, L.P. Lai, and K.L. Hsu et al. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele Hypertension 41 2003 9 15
29. M.J. Delmonico, R.E. Ferrell, A. Meerasahib, G.F. Martel, S.M. Roth, and M.C. Kostek et al. Blood pressure response to strength training may be influenced by angiotensinogen A-20C and angiotensin II type I receptor A1166C genotypes in older men and women J Am Geriatr Soc 53 2005 204 210
30. S. De Denus, M. Zakrzewski-Jakubiak, M.P. Dubé, F. Bélanger, S. Lepage, and M.H. Leblanc et al. Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan Ann Pharmacother 42 2008 925 932
31. Y. Liu, C. Zhuoma, G. Shan, C. Cui, S. Hou, and W. Qin et al. A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations Hypertens Res 25 2002 515 521